Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020
The global next generation sequencing market is dynamic and witnessing many changes with new products being introduced. The global NGS market will be worth $2.5 billion in 2014 and is poised to reach $8.7 billion by 2020.
The NGS market segments such as pre-sequencing products and services, NGS platforms, sequencing services and data analysis/bioinformatics are rapidly growing markets. The overall NGS market is flourishing by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. Developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions are major opportunities for this market.
NGS services market is one of the key segments in the NGS market which is estimated to grow at a CAGR of 24.0% by 2020. The growth is driven by increasing demand in diagnostics and pharmaceutical and biotechnology companies.
Sequencing by Synthesis technology will be the fastest growing technology in the coming years. SBS technology has wide applications in the NGS market and can be used for both single read and pair end libraries. Hence the demand for platforms such as HiSeq X Ten, NextSeq 500 and MiSeq is also high.
Presequencing products and services market will also witness high growth and is estimated to grow at 23.5% CAGR in the next six years. The growth can be attributed to the increasing demand for presequencing consumables and instruments as the quality of the end product depends on the presequencing treatment. The growing need for standardized sample preparation solutions and increasing automation in the pre-sequencing workflow step are drivers of this market.
The study is confined to platforms, consumables and services provided by top 4 companies, Illumina, Thermo Fisher (Life Technologies), Roche and Pacific Biosciences. It does not include other NGS platforms and miscellaneous consumables/reagents offered by other companies. Also, market estimation does not consider upcoming technologies or platforms.
This research report covers end-to-end market for NGS in terms of the workflow; presequencing, NGS platforms, consumables and services, sequencing services and bioinformatics market. From an insight perspective, this research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), and technological trends, globally. The report also offers market shares, sizes, and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of the patient monitoring market, high-growth regions, and the initiatives of their respective governments.
The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the patient monitoring market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.
The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
The report provides insights on the following points:
The NGS market segments such as pre-sequencing products and services, NGS platforms, sequencing services and data analysis/bioinformatics are rapidly growing markets. The overall NGS market is flourishing by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. Developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions are major opportunities for this market.
NGS services market is one of the key segments in the NGS market which is estimated to grow at a CAGR of 24.0% by 2020. The growth is driven by increasing demand in diagnostics and pharmaceutical and biotechnology companies.
Sequencing by Synthesis technology will be the fastest growing technology in the coming years. SBS technology has wide applications in the NGS market and can be used for both single read and pair end libraries. Hence the demand for platforms such as HiSeq X Ten, NextSeq 500 and MiSeq is also high.
Presequencing products and services market will also witness high growth and is estimated to grow at 23.5% CAGR in the next six years. The growth can be attributed to the increasing demand for presequencing consumables and instruments as the quality of the end product depends on the presequencing treatment. The growing need for standardized sample preparation solutions and increasing automation in the pre-sequencing workflow step are drivers of this market.
The study is confined to platforms, consumables and services provided by top 4 companies, Illumina, Thermo Fisher (Life Technologies), Roche and Pacific Biosciences. It does not include other NGS platforms and miscellaneous consumables/reagents offered by other companies. Also, market estimation does not consider upcoming technologies or platforms.
This research report covers end-to-end market for NGS in terms of the workflow; presequencing, NGS platforms, consumables and services, sequencing services and bioinformatics market. From an insight perspective, this research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), and technological trends, globally. The report also offers market shares, sizes, and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of the patient monitoring market, high-growth regions, and the initiatives of their respective governments.
The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the patient monitoring market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.
The above-mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
The report provides insights on the following points:
- Market Penetration: Comprehensive information on product portfolios of the top players in the NGS market. The report analyzes the next generation sequencing market by product, application, end user, and geography
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the NGS market
- Competitive Assessment: In-depth assessment of the market strategies, geographical and business segments, and product portfolios of the leading players in the global NGS market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various NGS sequencing products across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the NGS market
1 INTRODUCTION
1.1 Objectives Of The Study
1.2 Markets Covered
1.3 Stakeholders
1.4 Market Scope
2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Market Crackdown And Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions
2.3.3.1 Key Industry Insights
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 Attractive Market Opportunities In The Next-Generation Sequencing (NGS) Market
4.3 Nxt Generation sequencing Market, By Product Segment
4.4 NGS Platform Market Size (Units)
4.5 NGS Market Growth Opportunities, By Geography
4.6 Life Cycle Analysis, By Geography
4.7 NGS Market In Asian Region
4.8 Company Market Share Analysis, By Geography
4.9 NGS Market, By Application
5 MARKET OVERVIEW
5.1 Introduction
5.2 Evolution
5.3 Market Segmentation
5.4 Market Dynamics
5.4.1 Drivers
5.4.1.1 Cost And Speed To Drive The Growth Of NGS Technology
5.4.1.2 Substitution Of Microarray Technology By NGS To Boost Market Growth
5.4.1.3 Embracement Of NGS Technology By New Consumers To Propel The Market
5.4.1.4 Increase In Practice For New Scientific Applications To Boost Growth Of NGS Market
5.4.1.5 Research Laboratories And Academicians Promoting NGS
5.4.1.6 Global Alliances AmoNGSt Leading Research Institutes To Trigger Drug Discovery, Thus Increase The Demand Of NGS
5.4.1.7 Entry Of New Players Propelling The Growth Of The NGS Market
5.4.2 Restraints
5.4.2.1 High Reliability On Grants To Restrict Growth
5.4.2.2 Decrease In Capital Expenditure From Academic Institutes To Hinder The Sale Of Platforms
5.4.2.3 Accuracy & Standardization Concerns In Diagnostic Testing
5.4.2.4 Ethical And Legal Issues Related To Next-Generation Sequencing To Hinder The Adoption, Albeit To A Less Extent
5.4.3 Opportunities
5.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues For Investments In NGS Technology
5.4.3.2 Pre-Sequencing A High Growth Opportunity
5.4.3.3 Cloud Computing, A Prospective Service
5.4.4 Challenges
5.4.4.1 Interpretation Of Complex Data From NGS Platforms
5.4.5 Market Trend
5.4.5.1 Shift Of Focus Towards Third-Generation Sequencing
5.4.6 Burning Issues
5.4.6.1 Data Storage An Impediment To NGS Sequencing
5.4.6.2 Reduction In Cost To Sequence Human Genomes
5.4.7 Winning Imperative
5.4.7.1 Improved Collaborative Ties Between Industry And Academic & Research Institutes
6 INDUSTRY TRENDS
6.1 Value Chain Analysis
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power Of Buyers
6.2.4 Bargaining Power Of Suppliers
6.2.5 Competitive Rivalry Among Exisiting Firms
6.3 Technological Development Road-Map
6.3.1 Sanger Sequencing
6.3.2 Massively Parallel Sequencing (Next Generation Sequencing)
6.3.3 Single Molecule Real Time (Smrt) Sequencing
6.3.4 Nanopore Sequencing
6.4 Technological Trends
6.4.1 Nanopore Sequencing Technology
6.4.1.1 Oxford Nanopore Technologies
6.4.1.2 Roche (Genia Technologies)
6.4.1.3 Electronic Biosciences
6.4.2 Sequencing By Hybridization Technology (Gnubio)
6.4.3 Genius (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (Genapsys)
6.4.4 Lightning Terminator Sequencing Technology (Lasergen)
6.4.5 Optical Nanopore Sequencing Technology (Noblegen)
6.4.6 Nanowire Biosensor Sequencing Technology (Quantumdx)
7 GLOBAL NGS MARKET, BY STEPS IN WORKFLOW
7.1 Introduction
7.2 Pre-Sequencing Products & Services Market
7.2.1 Sample Preparation
7.2.1.1 DNA Fragmentation, End Repair, A-Tailing And Size Selection
7.2.1.2 Library Preparation
7.2.1.3 Target Enrichment
7.2.1.4 Quality Control
7.3 Sequencing Platforms Market
7.3.1 Illumina
7.3.1.1 Hiseq Series
7.3.1.2 Hiseq X Ten
7.3.1.3 Genome Analyzer Iix
7.3.1.3.1 Low Technological Advancements Will Result Into Downfall Of Ga Iix
7.3.1.4 Miseq
7.3.1.5 Nextseq500
7.3.2 Thermo Fisher Scientific (Life Technologies)
7.3.2.1 Solid Series
7.3.2.1.1 Solid Series Shows Minimal Scope For Growth
7.3.2.2 Ion Torrent Platforms
7.3.2.2.1 Ion Torrent Pgm
7.3.2.2.1.1 Currently Ion Torrent Pgm Exceeds The Unit Sales As Compared To Its Competitor Miseq
7.3.2.2.2 Ion Proton
7.3.2.2.2.1 Ion Proton Will Be One Of The Fast Growing Platforms
7.3.3 454 Roche
7.3.3.1 GS Junior Sales Stopped In 2013 And GS Flx+ Will Grow At Slow Pace Till 2016
7.3.3.2 GS Junior
7.3.3.3 GS Flx+
7.3.4 Pacific Biosciences
7.3.4.1 Pacbio Rs Ii
7.4 Sequencing Services Market
7.5 NGS Data Analysis, Storage, And Management (Bioinformatics) Market
7.5.1 Open-Source Applications Contribute 75% To The Overall NGS Bioinformatics Solutions Market
7.5.2 NGS Data Analysis, By Product
7.5.2.1 NGS Data Analysis Software & Workbenches
7.5.2.2 NGS Data Analysis Services
7.5.3 NGS Data Analysis, By Application
7.5.3.1 Whole-Genome Sequencing
7.5.3.2 Exome Sequencing
7.5.3.3 Targeted Re-Sequencing
7.5.3.4 De Novo Sequencing
7.5.3.5 RNA-Seq
7.5.3.6 Chip-Seq
7.5.3.7 Methyl-Seq
7.5.3.8 Others
7.5.4 NGS Storage, Management & Cloud Computing Solutions
8 NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
8.1 Introduction
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs To Be The Fastest-Growing Technology
8.3 Ion Semiconductor Sequencing
8.3.1 Ion Semiconductor Sequencing, A Fast-Growing Market
8.4 Sequencing By Ligation (Sbl)
8.4.1 Sbl Technology To Witness Negative Growth
8.5 Pyrosequencing
8.5.1 Pyrosequencing To Grow At A Negative Rate
8.6 Single Molecule Realtime Sequencing (Smrt)
8.6.1 Smrt Technology Has Limited Applications
9 GLOBAL NGS APPLICATION MARKET
9.1 Introduction
9.2 Diagnostics
9.2.1 Diagnostics Market Will Grow With Addition Of Wider Applications
9.2.2 Cancer Diagnostics To Drive The Market
9.3 Drug Discovery
9.3.1 Focus On Targeted Therapy To Boost The Next Generation Sequencing Market
9.4 Biomarker Discovery
9.4.1 Biomarker Discovery Application To Grow At A High Rate
9.5 Personalized Medicine
9.5.1 Personalized Medicine Offers Huge Potential Market
9.6 Agriculture & Animal Research
9.6.1 Applications In Crop Research & Animal Biotechnology To Boost The Next Generation Sequencing Market
9.7 Other Applications (Marine Research, Research In Bio-Fuels, Forensic Medicine, Phyleogeograpic & Phylogenetic Studies)
10 NEXT GENERATION SEQUENCING MARKET, BY END-USER
10.1 Introduction
10.1.1 Research Centers, Academic & Government Institutes
10.1.1.1 NGS Is A Research-Driven Market, Hence Highest Market Share
10.1.2 Hospitals & Clinics
10.1.2.1 Segment To Show Highest Growth Rate
10.1.3 Pharmaceutical & Biotechnology Companies
10.1.3.1 Targeted Therapy, Biomarker Research To Boost Segment Growth
10.1.4 Other End-Users (Npo, Agrigenomics Organizations, Consumer Genomic Companies)
11 NEXT GENERATION SEQUENCING MARKET, BY GEOGRAPHY
11.1 Introduction
11.2 North America
11.2.1 Government Funding To Boost The U.S. Market
11.2.2 Funds By Canadian Government Strives To Boost Next Generation Sequencing Market
11.3 Europe
11.3.1 Germany,U.K., And Belgium Are The Hubs For Scientific Research
11.3.2 Investments In Rare Disease Research Likely To Boost The NGS Market In Europe
11.3.3 Increasing Funding For Molecular Diagnostics In Europe Is Likely To Propel The Growth Of The Whole Exome Sequencing Market
11.4 Asia
11.4.1 China: Lucrative Market For NGS Products And Services Market
11.4.2 Regular Funding From The Indian Government, An Impetus To The NGS Market
11.5 Rest Of The World (Row)
11.5.1 Bioinformatics & Biotechnology Research In Latin America To Boost The Demand For NGS Instruments & Services
11.5.2 Flourishing Bio-Research Centers & Financial Support In Australia & Brazil Will Propel The Market
12 COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Market Share Analysis
12.2.1 Global NGS Platform Market
12.3 New Product Launches
12.4 Agreements And Partnerships
12.5 Mergers & Acquisitions
12.6 Expansions
13 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)
13.1 Introduction
13.2 454 Life Sciences Corporation (Roche Holding Ag)
13.2.1 Business Overview
13.2.2 Financials
13.2.3 Products & Services
13.2.4 Strategy
13.2.5 Recent Developments
13.3 Agilent Technologies, Inc.
13.3.1 Business Overview
13.3.2 Financials
13.3.3 Products And Services
13.3.4 Key Strategy
13.3.5 Recent Developments
13.4 Bgi (Beijing Genomics Institute)
13.4.1 Business Overview
13.4.2 Financials
13.4.3 Products & Services
13.4.4 Key Strategy
13.4.5 Recent Developments
13.5 Biomatters, Ltd.
13.5.1 Business Overview
13.5.2 Financials
13.5.3 Products & Services
13.5.4 Key Strategy
13.5.5 Recent Developments
13.6 Clc Bio (Acquired By Qiagen)
13.6.1 Business Overview
13.6.2 Financials
13.6.3 Products & Services
13.6.4 Key Strategy
13.6.5 Recent Developments
13.7 Dnastar, Inc.
13.7.1 Business Overview
13.7.2 Financials
13.7.3 Products & Services
13.7.4 Key Strategy
13.7.5 Recent Developments
13.8 Gatc Biotech Ag
13.8.1 Business Overview
13.8.2 Financials
13.8.3 Products & Services
13.8.4 Key Strategy
13.8.5 Recent Developments
13.9 Genomatix Software Gmbh
13.9.1 Business Overview
13.9.2 Financials
13.9.3 Products & Services
13.9.4 Key Strategy
13.9.5 Recent Developments
13.1 Illumina, Inc.
13.10.1 Business Overview
13.10.2 Financials
13.10.3 Products & Services
13.10.4 Key Strategy
13.10.5 Recent Developments
13.10.6 Swot
13.10.7 Mnm View
13.11 Knome, Inc.
13.11.1 Business Overview
13.11.2 Financials
13.11.3 Products & Services
13.11.4 Key Strategy
13.11.5 Recent Developments
13.12 Life Technologies Corporation (Thermo Fisher Scientific)
13.12.1 Business Overview
13.12.2 Financials
13.12.3 Products & Services
13.12.4 Key Strategy
13.12.5 Recent Developments
13.12.6 Swot
13.12.7 Mnm View
13.13 Macrogen, Inc.
13.13.1 Business Overview
13.13.2 Financials
13.13.3 Products & Services
13.13.4 Key Strategy
13.13.5 Recent Developments
13.14 Oxford Nanopore Technologies, Ltd.
13.14.1 Overview
13.14.2 Financials
13.14.3 Products & Services
13.14.4 Key Strategy
13.14.5 Recent Developments
13.15 Pacific Biosciences
13.15.1 Business Overview
13.15.2 Financials
13.15.3 Products & Services
13.15.4 Key Strategy
13.15.5 Recent Developments
13.15.6 Swot
13.15.7 Mnm View
13.16 Partek Incorporated
13.16.1 Business Overview
13.16.2 Financials
13.16.3 Products & Services
13.16.4 Key Strategy
13.16.5 Recent Developments
13.17 Perkin Elmer, Inc.
13.17.1 Business Overview
13.17.2 Financials
13.17.3 Products & Services
13.17.4 Key Strategy
13.17.5 Recent Developments
13.18 Qiagen N.V.
13.18.1 Business Overview
13.18.2 Financials
13.18.3 Products & Services
13.18.4 Key Strategy
13.18.5 Recent Developments (Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.)
14 APPENDIX
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Related Reports
14.5 Introducing Rt: Real Time Market Intelligence
1.1 Objectives Of The Study
1.2 Markets Covered
1.3 Stakeholders
1.4 Market Scope
2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Market Crackdown And Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions
2.3.3.1 Key Industry Insights
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 Attractive Market Opportunities In The Next-Generation Sequencing (NGS) Market
4.3 Nxt Generation sequencing Market, By Product Segment
4.4 NGS Platform Market Size (Units)
4.5 NGS Market Growth Opportunities, By Geography
4.6 Life Cycle Analysis, By Geography
4.7 NGS Market In Asian Region
4.8 Company Market Share Analysis, By Geography
4.9 NGS Market, By Application
5 MARKET OVERVIEW
5.1 Introduction
5.2 Evolution
5.3 Market Segmentation
5.4 Market Dynamics
5.4.1 Drivers
5.4.1.1 Cost And Speed To Drive The Growth Of NGS Technology
5.4.1.2 Substitution Of Microarray Technology By NGS To Boost Market Growth
5.4.1.3 Embracement Of NGS Technology By New Consumers To Propel The Market
5.4.1.4 Increase In Practice For New Scientific Applications To Boost Growth Of NGS Market
5.4.1.5 Research Laboratories And Academicians Promoting NGS
5.4.1.6 Global Alliances AmoNGSt Leading Research Institutes To Trigger Drug Discovery, Thus Increase The Demand Of NGS
5.4.1.7 Entry Of New Players Propelling The Growth Of The NGS Market
5.4.2 Restraints
5.4.2.1 High Reliability On Grants To Restrict Growth
5.4.2.2 Decrease In Capital Expenditure From Academic Institutes To Hinder The Sale Of Platforms
5.4.2.3 Accuracy & Standardization Concerns In Diagnostic Testing
5.4.2.4 Ethical And Legal Issues Related To Next-Generation Sequencing To Hinder The Adoption, Albeit To A Less Extent
5.4.3 Opportunities
5.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues For Investments In NGS Technology
5.4.3.2 Pre-Sequencing A High Growth Opportunity
5.4.3.3 Cloud Computing, A Prospective Service
5.4.4 Challenges
5.4.4.1 Interpretation Of Complex Data From NGS Platforms
5.4.5 Market Trend
5.4.5.1 Shift Of Focus Towards Third-Generation Sequencing
5.4.6 Burning Issues
5.4.6.1 Data Storage An Impediment To NGS Sequencing
5.4.6.2 Reduction In Cost To Sequence Human Genomes
5.4.7 Winning Imperative
5.4.7.1 Improved Collaborative Ties Between Industry And Academic & Research Institutes
6 INDUSTRY TRENDS
6.1 Value Chain Analysis
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power Of Buyers
6.2.4 Bargaining Power Of Suppliers
6.2.5 Competitive Rivalry Among Exisiting Firms
6.3 Technological Development Road-Map
6.3.1 Sanger Sequencing
6.3.2 Massively Parallel Sequencing (Next Generation Sequencing)
6.3.3 Single Molecule Real Time (Smrt) Sequencing
6.3.4 Nanopore Sequencing
6.4 Technological Trends
6.4.1 Nanopore Sequencing Technology
6.4.1.1 Oxford Nanopore Technologies
6.4.1.2 Roche (Genia Technologies)
6.4.1.3 Electronic Biosciences
6.4.2 Sequencing By Hybridization Technology (Gnubio)
6.4.3 Genius (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (Genapsys)
6.4.4 Lightning Terminator Sequencing Technology (Lasergen)
6.4.5 Optical Nanopore Sequencing Technology (Noblegen)
6.4.6 Nanowire Biosensor Sequencing Technology (Quantumdx)
7 GLOBAL NGS MARKET, BY STEPS IN WORKFLOW
7.1 Introduction
7.2 Pre-Sequencing Products & Services Market
7.2.1 Sample Preparation
7.2.1.1 DNA Fragmentation, End Repair, A-Tailing And Size Selection
7.2.1.2 Library Preparation
7.2.1.3 Target Enrichment
7.2.1.4 Quality Control
7.3 Sequencing Platforms Market
7.3.1 Illumina
7.3.1.1 Hiseq Series
7.3.1.2 Hiseq X Ten
7.3.1.3 Genome Analyzer Iix
7.3.1.3.1 Low Technological Advancements Will Result Into Downfall Of Ga Iix
7.3.1.4 Miseq
7.3.1.5 Nextseq500
7.3.2 Thermo Fisher Scientific (Life Technologies)
7.3.2.1 Solid Series
7.3.2.1.1 Solid Series Shows Minimal Scope For Growth
7.3.2.2 Ion Torrent Platforms
7.3.2.2.1 Ion Torrent Pgm
7.3.2.2.1.1 Currently Ion Torrent Pgm Exceeds The Unit Sales As Compared To Its Competitor Miseq
7.3.2.2.2 Ion Proton
7.3.2.2.2.1 Ion Proton Will Be One Of The Fast Growing Platforms
7.3.3 454 Roche
7.3.3.1 GS Junior Sales Stopped In 2013 And GS Flx+ Will Grow At Slow Pace Till 2016
7.3.3.2 GS Junior
7.3.3.3 GS Flx+
7.3.4 Pacific Biosciences
7.3.4.1 Pacbio Rs Ii
7.4 Sequencing Services Market
7.5 NGS Data Analysis, Storage, And Management (Bioinformatics) Market
7.5.1 Open-Source Applications Contribute 75% To The Overall NGS Bioinformatics Solutions Market
7.5.2 NGS Data Analysis, By Product
7.5.2.1 NGS Data Analysis Software & Workbenches
7.5.2.2 NGS Data Analysis Services
7.5.3 NGS Data Analysis, By Application
7.5.3.1 Whole-Genome Sequencing
7.5.3.2 Exome Sequencing
7.5.3.3 Targeted Re-Sequencing
7.5.3.4 De Novo Sequencing
7.5.3.5 RNA-Seq
7.5.3.6 Chip-Seq
7.5.3.7 Methyl-Seq
7.5.3.8 Others
7.5.4 NGS Storage, Management & Cloud Computing Solutions
8 NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
8.1 Introduction
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs To Be The Fastest-Growing Technology
8.3 Ion Semiconductor Sequencing
8.3.1 Ion Semiconductor Sequencing, A Fast-Growing Market
8.4 Sequencing By Ligation (Sbl)
8.4.1 Sbl Technology To Witness Negative Growth
8.5 Pyrosequencing
8.5.1 Pyrosequencing To Grow At A Negative Rate
8.6 Single Molecule Realtime Sequencing (Smrt)
8.6.1 Smrt Technology Has Limited Applications
9 GLOBAL NGS APPLICATION MARKET
9.1 Introduction
9.2 Diagnostics
9.2.1 Diagnostics Market Will Grow With Addition Of Wider Applications
9.2.2 Cancer Diagnostics To Drive The Market
9.3 Drug Discovery
9.3.1 Focus On Targeted Therapy To Boost The Next Generation Sequencing Market
9.4 Biomarker Discovery
9.4.1 Biomarker Discovery Application To Grow At A High Rate
9.5 Personalized Medicine
9.5.1 Personalized Medicine Offers Huge Potential Market
9.6 Agriculture & Animal Research
9.6.1 Applications In Crop Research & Animal Biotechnology To Boost The Next Generation Sequencing Market
9.7 Other Applications (Marine Research, Research In Bio-Fuels, Forensic Medicine, Phyleogeograpic & Phylogenetic Studies)
10 NEXT GENERATION SEQUENCING MARKET, BY END-USER
10.1 Introduction
10.1.1 Research Centers, Academic & Government Institutes
10.1.1.1 NGS Is A Research-Driven Market, Hence Highest Market Share
10.1.2 Hospitals & Clinics
10.1.2.1 Segment To Show Highest Growth Rate
10.1.3 Pharmaceutical & Biotechnology Companies
10.1.3.1 Targeted Therapy, Biomarker Research To Boost Segment Growth
10.1.4 Other End-Users (Npo, Agrigenomics Organizations, Consumer Genomic Companies)
11 NEXT GENERATION SEQUENCING MARKET, BY GEOGRAPHY
11.1 Introduction
11.2 North America
11.2.1 Government Funding To Boost The U.S. Market
11.2.2 Funds By Canadian Government Strives To Boost Next Generation Sequencing Market
11.3 Europe
11.3.1 Germany,U.K., And Belgium Are The Hubs For Scientific Research
11.3.2 Investments In Rare Disease Research Likely To Boost The NGS Market In Europe
11.3.3 Increasing Funding For Molecular Diagnostics In Europe Is Likely To Propel The Growth Of The Whole Exome Sequencing Market
11.4 Asia
11.4.1 China: Lucrative Market For NGS Products And Services Market
11.4.2 Regular Funding From The Indian Government, An Impetus To The NGS Market
11.5 Rest Of The World (Row)
11.5.1 Bioinformatics & Biotechnology Research In Latin America To Boost The Demand For NGS Instruments & Services
11.5.2 Flourishing Bio-Research Centers & Financial Support In Australia & Brazil Will Propel The Market
12 COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Market Share Analysis
12.2.1 Global NGS Platform Market
12.3 New Product Launches
12.4 Agreements And Partnerships
12.5 Mergers & Acquisitions
12.6 Expansions
13 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)
13.1 Introduction
13.2 454 Life Sciences Corporation (Roche Holding Ag)
13.2.1 Business Overview
13.2.2 Financials
13.2.3 Products & Services
13.2.4 Strategy
13.2.5 Recent Developments
13.3 Agilent Technologies, Inc.
13.3.1 Business Overview
13.3.2 Financials
13.3.3 Products And Services
13.3.4 Key Strategy
13.3.5 Recent Developments
13.4 Bgi (Beijing Genomics Institute)
13.4.1 Business Overview
13.4.2 Financials
13.4.3 Products & Services
13.4.4 Key Strategy
13.4.5 Recent Developments
13.5 Biomatters, Ltd.
13.5.1 Business Overview
13.5.2 Financials
13.5.3 Products & Services
13.5.4 Key Strategy
13.5.5 Recent Developments
13.6 Clc Bio (Acquired By Qiagen)
13.6.1 Business Overview
13.6.2 Financials
13.6.3 Products & Services
13.6.4 Key Strategy
13.6.5 Recent Developments
13.7 Dnastar, Inc.
13.7.1 Business Overview
13.7.2 Financials
13.7.3 Products & Services
13.7.4 Key Strategy
13.7.5 Recent Developments
13.8 Gatc Biotech Ag
13.8.1 Business Overview
13.8.2 Financials
13.8.3 Products & Services
13.8.4 Key Strategy
13.8.5 Recent Developments
13.9 Genomatix Software Gmbh
13.9.1 Business Overview
13.9.2 Financials
13.9.3 Products & Services
13.9.4 Key Strategy
13.9.5 Recent Developments
13.1 Illumina, Inc.
13.10.1 Business Overview
13.10.2 Financials
13.10.3 Products & Services
13.10.4 Key Strategy
13.10.5 Recent Developments
13.10.6 Swot
13.10.7 Mnm View
13.11 Knome, Inc.
13.11.1 Business Overview
13.11.2 Financials
13.11.3 Products & Services
13.11.4 Key Strategy
13.11.5 Recent Developments
13.12 Life Technologies Corporation (Thermo Fisher Scientific)
13.12.1 Business Overview
13.12.2 Financials
13.12.3 Products & Services
13.12.4 Key Strategy
13.12.5 Recent Developments
13.12.6 Swot
13.12.7 Mnm View
13.13 Macrogen, Inc.
13.13.1 Business Overview
13.13.2 Financials
13.13.3 Products & Services
13.13.4 Key Strategy
13.13.5 Recent Developments
13.14 Oxford Nanopore Technologies, Ltd.
13.14.1 Overview
13.14.2 Financials
13.14.3 Products & Services
13.14.4 Key Strategy
13.14.5 Recent Developments
13.15 Pacific Biosciences
13.15.1 Business Overview
13.15.2 Financials
13.15.3 Products & Services
13.15.4 Key Strategy
13.15.5 Recent Developments
13.15.6 Swot
13.15.7 Mnm View
13.16 Partek Incorporated
13.16.1 Business Overview
13.16.2 Financials
13.16.3 Products & Services
13.16.4 Key Strategy
13.16.5 Recent Developments
13.17 Perkin Elmer, Inc.
13.17.1 Business Overview
13.17.2 Financials
13.17.3 Products & Services
13.17.4 Key Strategy
13.17.5 Recent Developments
13.18 Qiagen N.V.
13.18.1 Business Overview
13.18.2 Financials
13.18.3 Products & Services
13.18.4 Key Strategy
13.18.5 Recent Developments (Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.)
14 APPENDIX
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Related Reports
14.5 Introducing Rt: Real Time Market Intelligence
LIST OF TABLES
Table 1 Overall Global Next Generation Sequencing Market, By Products & Services, 2012–2020 ($Million)
Table 2 Technological Advancements, Decreasing Sequencing Costs Propelling Growth Of Next Generation Sequencing Market
Table 3 Comparison Between NGS & Microarray Systems
Table 4 Global Next Generation Sequencing Market Size, By Product, 2012–2020 ($Million)
Table 5 Next Generation Sequencing Market Size, By Geography, 2012 – 2020 ($Million)
Table 6 Global Pre-Sequencing Market, By Process, 2012 – 2020 ($Million)
Table 7 Next Generation Sequencing Market Size For Pre-Sequencing, By Geography, 2012–2020 ($Million)
Table 8 Pre-Sequencing Market Size For Dna Fragmentation, End Repair, A-Tailing And Size Selection, By Geography, 2012-2020 ($Million)
Table 9 Pre-Sequencing Market Size For Library Preparation, By Geography, 2012-2020 ($Million)
Table 10 Pre-Sequencing Market Size For Target Enrichment, By Geography 2012-2020 ($Million)
Table 11 Pre-Sequencing Market Size For Quality Control, By Geography, 2012-2020 ($Million)
Table 12 Global Next Generation Sequencing Market Size For Instruments, Products And Services, 2012–2020 ($Million)
Table 13 NGS Platform Market, By Geography, 2012–2020 ($Million)
Table 14 Global NGS Market Size For Instruments, By Players, 2012–2020 ($Million)
Table 15 Global Next Generation Sequencing Market Size For Instruments, By Players, 2012–2020 (No. Of Units Sold)
Table 16 Global Market Size For Platforms, By Brand, 2012–2020 ($Million)
Table 17 Global Market Size For Instruments, By Brand, 2012–2020 (No. Of Units)
Table 18 Global Market Size For Consumables, By Player, 2012–2020 ($Million)
Table 19 Global Market Size For Post-Purchase Services, By Player, 2012–2020 ($Million)
Table 20 Global Market Size For Illumina Platforms, 2012–2020 ($Million)
Table 21 Global Next Generation Sequencing Market Size For Illumina Platforms, By Product, 2012–2020 (No. Of Units)
Table 22 Next Generation Sequencing Market Size For Illumina Platforms, By Geography, 2012–2020 ($Million)
Table 23 Next Generation Sequencing Market Size For Illumina Consumables/Reagents Market, By Geography, 2012–2020 ($Million)
Table 24 Market Size For Illumina Services, By Geography, 2012–2020 ($Million)
Table 25 Hiseq Sequencing Instrument Market, By Geography, 2012–2020 ($Million)
Table 26 Key End-Customer Of Hiseq X Ten In 2014
Table 27 Next Generation Sequencing Market Size For Hiseq X Ten Instrument, By Geography, 2012–2020 ($Million)
Table 28 Market Size For Genome Analyzer Iix Sequencing Platform, By Geography, 2012–2020 ($Million)
Table 29 Market Size For Miseq Platform, By Geography, 2012–2020 ($Million)
Table 30 Market Size For Nextseq 500 Sequencing Platform, By Geography, 2012–2020 ($Million)
Table 31 Global Next Generation SequencingMarket Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 32 Global Next Generation Sequencing Market Size For Thermo Fisher, By Brand, 2012–2020 (No. Of Units)
Table 33 Next Generation Sequencing Market Size For Thermo Fisher Sequencing Platforms, By Geography, 2012–2020 ($Million)
Table 34 Market Size For Thermo Fisher Consumables/Reagents, By Geography, 2012–2020 ($Million)
Table 35 Market Size For Thermo Fisher Services, By Geography, 2012–2020 ($Million)
Table 36 Market Size For Thermo Fisher Solid Series Instrument, By Geography, 2012–2020 ($Million)
Table 37 Market Size For Thermo Fisher Ion Torrent Pgm Instrument, By Geography, 2012–2020 ($Million)
Table 38 Market Size For Thermo Fisher Ion Proton Instrument, By Geography, 2012-2020 ($Million)
Table 39 Global Next Generation Sequencing Market Size For 454 Roche Platforms, 2012-2020, ($Million)
Table 40 454 Roche: NGS Platform Market, 2012–2020 (No. Of Units)
Table 41 454 Roche NGS Platform Market, By Geography, 2012–2020 ($Million)
Table 42 Next Generation Sequencing Market Size For 454 Roche Consumables/Reagents, By Geography, 2012–2020 ($Million)
Table 43 Market Size For 454 Roche Services, By Geography, 2012-2020 ($Million)
Table 44 Gs Junior Market, By Geography, 2012–2020 ($Million)
Table 45 Gs Flx+ Market, By Geography, 2012–2020 ($Million)
Table 46 Pacific Biosciences: NGS Platforms Market, 2012–2020 ($Million)
Table 47 Pacific Biosciences: NGS Instrument Market, By Brand, 2012–2020 (No.Of Units)
Table 48 Market Size For Pacific Biosciences Platforms, By Geography, 2012-2020 ($Million)
Table 49 Market Size For Pacific Biosciences Consumables/Reagents, By Geography, 2012-2020 ($Million)
Table 50 Market Size For Pacific Biosciences Services, By Geography, 2012-2020 ($Million)
Table 51 Market Size For Pacbio Rs Ii Instruments, By Geography, 2012–2020 ($Million)
Table 52 Global Next Generation Sequencing Market Size For Sequencing Services, By Application, 2012–2020 ($Million)
Table 53 Next Generation Sequencing Market Size For Sequencing Services, By Geography, 2012-2020 ($Million)
Table 54 Global Next Generation Sequencing Market Size For Data Analysis, By Products And Services, 2012–2020 ($Million)
Table 55 Market Size For Data Analysis, By Geography, 2012-2020 ($Million)
Table 56 Market Size For Data Analysis Software & Workbenches Products, By Geography, 2012-2020 ($Million)
Table 57 Global Next Generation Sequencing Market Size For Software & Workbenches, By Application, 2012-2020 ($Million)
Table 58 Next Generation Sequencing Market Size For Data Analysis Services, By Geography, 2012-2020 ($Million)
Table 59 Global Next Generation Sequencing Market Size For Data Analysis Services, By Application, 2012-2020 ($Million)
Table 60 Global Market Size For Data Analysis, By Application, 2012-2020 ($Million)
Table 61 NGS Technologies, By Company
Table 62 Global Next Generation Sequencing Market Size, By Technology, 2012–2020 ($Million)
Table 63 Next Generation Sequencing Market Size For Sequencing By Synthesis Technology, By Geography, 2012–2020 ($Million)
Table 64 Market Size For Ion Semiconductor Sequencing Technology, By Geography, 2012–2020 ($Million)
Table 65 Next Generation Sequencing Market Size For Sequencing By Ligation Technology, By Geography, 2012–2020 ($Million)
Table 66 NGS Market Size For Pyrosequencing Technology, By Geography, 2012–2020 ($Million)
Table 67 Market Size For Single Molecule Real Time Sequencing, By Geography, 2012–2020 ($Million)
Table 68 Global Next Generation Sequencing Market, By Application, 2012–2020 ($Million)
Table 69 Global Next Generation Sequencing Market Size For Diagnostics, By Geography, 2012–2020 ($Million)
Table 70 NGS Market Size For Drug Discovery, By Geography, 2012–2020 ($Million)
Table 71 NGS Market Size For Biomarker Discovery, By Geography, 2012–2020 ($Million)
Table 72 Next Generation Sequencing Market Size For Personalized Medicine, By Geography, 2012–2020 ($Million)
Table 73 NGS Market Size For Agriculture & Animal Research, By Geography, 2012 – 2020 ($Million)
Table 74 NGS Market Size For Other Applications, By Geography, 2012–2020 ($Million)
Table 75 Global NGS Market, By End User, 2012-2020 ($Million)
Table 76 Next Generation Sequencing Market Size For Research Centers, Academic/Government Institutes Segment, By Geography, 2012-2020 ($Million)
Table 77 NGS Market Size For Hospitals & Clinics Segment, By Geography, 2012-2020 ($Million)
Table 78 Next Generation Sequencing Market Size For Pharmaceutical & Biotechnology Companies, By Geography, 2012-2020 ($Million)
Table 79 Market Size For Other End Users, By Geography, 2012-2020 ($Million)
Table 80 Market Size, By Geography, 2012–2020 ($Million)
Table 81 Market Size For Pre-Sequencing, By Geography, 2012–2020 ($Million)
Table 82 Market Size For Bioinformatics, By Geography, 2012–2020 ($Million)
Table 83 Next Generation Sequencing Market Size Services, By Geography, 2012–2020 ($Million)
Table 84 North America: Next Generation Sequencing Market Size, Byproducts And Services, 2012–2020 ($Million)
Table 85 North America: Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 86 North America: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 87 North America: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 88 North America: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 89 North America: Market Size For 454 Roche, By Product, 2012–2016 ($Million)
Table 90 North America: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 91 North America: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 92 North America: Market Size, By Technology, 2012–2020 ($Million)
Table 93 North America: Market Size, By Application, 2012–2020 ($Million)
Table 94 North America: NGS Market Size, By End User, 2012–2020 ($Million)
Table 95 Europe: Next Generation Sequencing Market Size, By Products And Services, 2012–2020 ($Million)
Table 96 Europe: NGS Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 97 Europe: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 98 Europe: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 99 Europe: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 100 Europe: Market Size For 454 Roche, By Product, 2012–2020 ($Million)
Table 101 Europe: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 102 Europe: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 103 Europe: Market Size, By Technology, 2012–2020 ($Million)
Table 104 Europe: Market Size, By Application, 2012–2020 ($Million)
Table 105 Europe: NGS Market Size, By End User, 2012–2020 ($Million)
Table 106 Asia: Next Generation Sequencing Market, Byproducts And Services, 2012–2020 ($Million)
Table 107 Asia: Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 108 Asia: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 109 Asia: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 110 Asia: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 111 Asia: Next Generation Sequencing Market Size For 454 Roche, By Product, 2012–2016 ($Million)
Table 112 Asia: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 113 Asia: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 114 Asia: Market Size, By Technology, 2012–2020 ($Million)
Table 115 Asia: Market Size, By Application, 2012–2020 ($Million)
Table 116 Asia: NGS Market Size, By End User, 2012–2020 ($Million)
Table 117 Row: Next Generation Sequencing Market, By Products And Services, 2012–2020 ($Million)
Table 118 Row: Next Generation Sequencing Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 119 Row: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 120 Row: Market Size For Illumina, By Product, 2014–2020 ($Million)
Table 121 Row: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 122 Row: Market Size For 454 Roche, By Product, 2012–2020 ($Million)
Table 123 Row: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 124 Row: Market Size, By Technology, 2012–2020 ($Million)
Table 125 Row: Market Size, By Application, 2012–2020 ($Million)
Table 126 Row: NGS Market Size, By End User, 2012–2020 ($Million)
Table 127 New Product Launches, 2012–2014
Table 128 Agreements And Partnerships, 2012–2014
Table 129 Mergers & Acquisitions, 2011–2014
Table 130 Expansion,2012-2014
Table 1 Overall Global Next Generation Sequencing Market, By Products & Services, 2012–2020 ($Million)
Table 2 Technological Advancements, Decreasing Sequencing Costs Propelling Growth Of Next Generation Sequencing Market
Table 3 Comparison Between NGS & Microarray Systems
Table 4 Global Next Generation Sequencing Market Size, By Product, 2012–2020 ($Million)
Table 5 Next Generation Sequencing Market Size, By Geography, 2012 – 2020 ($Million)
Table 6 Global Pre-Sequencing Market, By Process, 2012 – 2020 ($Million)
Table 7 Next Generation Sequencing Market Size For Pre-Sequencing, By Geography, 2012–2020 ($Million)
Table 8 Pre-Sequencing Market Size For Dna Fragmentation, End Repair, A-Tailing And Size Selection, By Geography, 2012-2020 ($Million)
Table 9 Pre-Sequencing Market Size For Library Preparation, By Geography, 2012-2020 ($Million)
Table 10 Pre-Sequencing Market Size For Target Enrichment, By Geography 2012-2020 ($Million)
Table 11 Pre-Sequencing Market Size For Quality Control, By Geography, 2012-2020 ($Million)
Table 12 Global Next Generation Sequencing Market Size For Instruments, Products And Services, 2012–2020 ($Million)
Table 13 NGS Platform Market, By Geography, 2012–2020 ($Million)
Table 14 Global NGS Market Size For Instruments, By Players, 2012–2020 ($Million)
Table 15 Global Next Generation Sequencing Market Size For Instruments, By Players, 2012–2020 (No. Of Units Sold)
Table 16 Global Market Size For Platforms, By Brand, 2012–2020 ($Million)
Table 17 Global Market Size For Instruments, By Brand, 2012–2020 (No. Of Units)
Table 18 Global Market Size For Consumables, By Player, 2012–2020 ($Million)
Table 19 Global Market Size For Post-Purchase Services, By Player, 2012–2020 ($Million)
Table 20 Global Market Size For Illumina Platforms, 2012–2020 ($Million)
Table 21 Global Next Generation Sequencing Market Size For Illumina Platforms, By Product, 2012–2020 (No. Of Units)
Table 22 Next Generation Sequencing Market Size For Illumina Platforms, By Geography, 2012–2020 ($Million)
Table 23 Next Generation Sequencing Market Size For Illumina Consumables/Reagents Market, By Geography, 2012–2020 ($Million)
Table 24 Market Size For Illumina Services, By Geography, 2012–2020 ($Million)
Table 25 Hiseq Sequencing Instrument Market, By Geography, 2012–2020 ($Million)
Table 26 Key End-Customer Of Hiseq X Ten In 2014
Table 27 Next Generation Sequencing Market Size For Hiseq X Ten Instrument, By Geography, 2012–2020 ($Million)
Table 28 Market Size For Genome Analyzer Iix Sequencing Platform, By Geography, 2012–2020 ($Million)
Table 29 Market Size For Miseq Platform, By Geography, 2012–2020 ($Million)
Table 30 Market Size For Nextseq 500 Sequencing Platform, By Geography, 2012–2020 ($Million)
Table 31 Global Next Generation SequencingMarket Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 32 Global Next Generation Sequencing Market Size For Thermo Fisher, By Brand, 2012–2020 (No. Of Units)
Table 33 Next Generation Sequencing Market Size For Thermo Fisher Sequencing Platforms, By Geography, 2012–2020 ($Million)
Table 34 Market Size For Thermo Fisher Consumables/Reagents, By Geography, 2012–2020 ($Million)
Table 35 Market Size For Thermo Fisher Services, By Geography, 2012–2020 ($Million)
Table 36 Market Size For Thermo Fisher Solid Series Instrument, By Geography, 2012–2020 ($Million)
Table 37 Market Size For Thermo Fisher Ion Torrent Pgm Instrument, By Geography, 2012–2020 ($Million)
Table 38 Market Size For Thermo Fisher Ion Proton Instrument, By Geography, 2012-2020 ($Million)
Table 39 Global Next Generation Sequencing Market Size For 454 Roche Platforms, 2012-2020, ($Million)
Table 40 454 Roche: NGS Platform Market, 2012–2020 (No. Of Units)
Table 41 454 Roche NGS Platform Market, By Geography, 2012–2020 ($Million)
Table 42 Next Generation Sequencing Market Size For 454 Roche Consumables/Reagents, By Geography, 2012–2020 ($Million)
Table 43 Market Size For 454 Roche Services, By Geography, 2012-2020 ($Million)
Table 44 Gs Junior Market, By Geography, 2012–2020 ($Million)
Table 45 Gs Flx+ Market, By Geography, 2012–2020 ($Million)
Table 46 Pacific Biosciences: NGS Platforms Market, 2012–2020 ($Million)
Table 47 Pacific Biosciences: NGS Instrument Market, By Brand, 2012–2020 (No.Of Units)
Table 48 Market Size For Pacific Biosciences Platforms, By Geography, 2012-2020 ($Million)
Table 49 Market Size For Pacific Biosciences Consumables/Reagents, By Geography, 2012-2020 ($Million)
Table 50 Market Size For Pacific Biosciences Services, By Geography, 2012-2020 ($Million)
Table 51 Market Size For Pacbio Rs Ii Instruments, By Geography, 2012–2020 ($Million)
Table 52 Global Next Generation Sequencing Market Size For Sequencing Services, By Application, 2012–2020 ($Million)
Table 53 Next Generation Sequencing Market Size For Sequencing Services, By Geography, 2012-2020 ($Million)
Table 54 Global Next Generation Sequencing Market Size For Data Analysis, By Products And Services, 2012–2020 ($Million)
Table 55 Market Size For Data Analysis, By Geography, 2012-2020 ($Million)
Table 56 Market Size For Data Analysis Software & Workbenches Products, By Geography, 2012-2020 ($Million)
Table 57 Global Next Generation Sequencing Market Size For Software & Workbenches, By Application, 2012-2020 ($Million)
Table 58 Next Generation Sequencing Market Size For Data Analysis Services, By Geography, 2012-2020 ($Million)
Table 59 Global Next Generation Sequencing Market Size For Data Analysis Services, By Application, 2012-2020 ($Million)
Table 60 Global Market Size For Data Analysis, By Application, 2012-2020 ($Million)
Table 61 NGS Technologies, By Company
Table 62 Global Next Generation Sequencing Market Size, By Technology, 2012–2020 ($Million)
Table 63 Next Generation Sequencing Market Size For Sequencing By Synthesis Technology, By Geography, 2012–2020 ($Million)
Table 64 Market Size For Ion Semiconductor Sequencing Technology, By Geography, 2012–2020 ($Million)
Table 65 Next Generation Sequencing Market Size For Sequencing By Ligation Technology, By Geography, 2012–2020 ($Million)
Table 66 NGS Market Size For Pyrosequencing Technology, By Geography, 2012–2020 ($Million)
Table 67 Market Size For Single Molecule Real Time Sequencing, By Geography, 2012–2020 ($Million)
Table 68 Global Next Generation Sequencing Market, By Application, 2012–2020 ($Million)
Table 69 Global Next Generation Sequencing Market Size For Diagnostics, By Geography, 2012–2020 ($Million)
Table 70 NGS Market Size For Drug Discovery, By Geography, 2012–2020 ($Million)
Table 71 NGS Market Size For Biomarker Discovery, By Geography, 2012–2020 ($Million)
Table 72 Next Generation Sequencing Market Size For Personalized Medicine, By Geography, 2012–2020 ($Million)
Table 73 NGS Market Size For Agriculture & Animal Research, By Geography, 2012 – 2020 ($Million)
Table 74 NGS Market Size For Other Applications, By Geography, 2012–2020 ($Million)
Table 75 Global NGS Market, By End User, 2012-2020 ($Million)
Table 76 Next Generation Sequencing Market Size For Research Centers, Academic/Government Institutes Segment, By Geography, 2012-2020 ($Million)
Table 77 NGS Market Size For Hospitals & Clinics Segment, By Geography, 2012-2020 ($Million)
Table 78 Next Generation Sequencing Market Size For Pharmaceutical & Biotechnology Companies, By Geography, 2012-2020 ($Million)
Table 79 Market Size For Other End Users, By Geography, 2012-2020 ($Million)
Table 80 Market Size, By Geography, 2012–2020 ($Million)
Table 81 Market Size For Pre-Sequencing, By Geography, 2012–2020 ($Million)
Table 82 Market Size For Bioinformatics, By Geography, 2012–2020 ($Million)
Table 83 Next Generation Sequencing Market Size Services, By Geography, 2012–2020 ($Million)
Table 84 North America: Next Generation Sequencing Market Size, Byproducts And Services, 2012–2020 ($Million)
Table 85 North America: Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 86 North America: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 87 North America: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 88 North America: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 89 North America: Market Size For 454 Roche, By Product, 2012–2016 ($Million)
Table 90 North America: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 91 North America: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 92 North America: Market Size, By Technology, 2012–2020 ($Million)
Table 93 North America: Market Size, By Application, 2012–2020 ($Million)
Table 94 North America: NGS Market Size, By End User, 2012–2020 ($Million)
Table 95 Europe: Next Generation Sequencing Market Size, By Products And Services, 2012–2020 ($Million)
Table 96 Europe: NGS Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 97 Europe: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 98 Europe: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 99 Europe: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 100 Europe: Market Size For 454 Roche, By Product, 2012–2020 ($Million)
Table 101 Europe: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 102 Europe: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 103 Europe: Market Size, By Technology, 2012–2020 ($Million)
Table 104 Europe: Market Size, By Application, 2012–2020 ($Million)
Table 105 Europe: NGS Market Size, By End User, 2012–2020 ($Million)
Table 106 Asia: Next Generation Sequencing Market, Byproducts And Services, 2012–2020 ($Million)
Table 107 Asia: Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 108 Asia: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 109 Asia: Market Size For Illumina, By Product, 2012–2020 ($Million)
Table 110 Asia: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 111 Asia: Next Generation Sequencing Market Size For 454 Roche, By Product, 2012–2016 ($Million)
Table 112 Asia: Market Size For Pacific Biosciences, By Product, 2012–2020 ($Million)
Table 113 Asia: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 114 Asia: Market Size, By Technology, 2012–2020 ($Million)
Table 115 Asia: Market Size, By Application, 2012–2020 ($Million)
Table 116 Asia: NGS Market Size, By End User, 2012–2020 ($Million)
Table 117 Row: Next Generation Sequencing Market, By Products And Services, 2012–2020 ($Million)
Table 118 Row: Next Generation Sequencing Market Size For Pre-Sequencing, By Product, 2012–2020 ($Million)
Table 119 Row: Market Size For Platforms, By Company, 2012–2020 ($Million)
Table 120 Row: Market Size For Illumina, By Product, 2014–2020 ($Million)
Table 121 Row: Market Size For Thermo Fisher (Life Technologies), By Product, 2012–2020 ($Million)
Table 122 Row: Market Size For 454 Roche, By Product, 2012–2020 ($Million)
Table 123 Row: Market Size For Bioinformatics, By Product, 2012–2020 ($Million)
Table 124 Row: Market Size, By Technology, 2012–2020 ($Million)
Table 125 Row: Market Size, By Application, 2012–2020 ($Million)
Table 126 Row: NGS Market Size, By End User, 2012–2020 ($Million)
Table 127 New Product Launches, 2012–2014
Table 128 Agreements And Partnerships, 2012–2014
Table 129 Mergers & Acquisitions, 2011–2014
Table 130 Expansion,2012-2014
Objectives Of The Study:
- To define, describe, and forecast the global next -generation sequencing market on the basis of products, technologies, applications, and end users
- To provide a detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, industry specific challenges, winning imperatives, and burning issues)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and details of the competitive landscape for market leaders
- To forecast the revenue of market segments with respect to four main geographies, namely, North America, Europe, Asia, and Rest of the World
- To strategically profile key players and comprehensively analyze their market shares and core competencies2
- To track and analyze competitive developments such as joint ventures, mergers and acquisitions, new product developments, and research and development in the nextgeneration sequencing market
The study covers the market of four major product segments of global next-generation sequencing (NGS) market, namely, pre-sequencing products and services, sequencing platforms, sequencing services, and data analysis/bioinformatics. The market is also segmented into technologies,applications, and end users.
The definition of the NGS products and services for this market study is as follows: Next-generation sequencing refers to non-Sanger-based high-throughput DNA sequencing technologies. Millions or billions of DNA strands can be sequenced in parallel, yielding substantially more throughput and minimizing the need for the fragment-cloning methods that are often used in Sanger sequencing of genomes.
In the report, three types of services are considered:
- Post-purchase Services (For Platforms)
- Sequencing Services
- Data Analysis Services
